| Literature DB >> 36181085 |
Jeongyoon Lee1, Jihyun An, Dong Hwan Lee, Jihyang Lee, Eunju Kim, Kyeongyoon Woo, Kyeong Hyo Kim.
Abstract
BACKGROUND: Neuroendocrine stress response induces physiological changes depending on the type of surgery and anesthesia. Although the optimal depth of neuromuscular blockade for reducing this response remains unknown, deep neuromuscular blockade is known to improve the surgical environment. Therefore, we hypothesized that a patient's stress response would be lower in surgical procedures under deep neuromuscular blockade than under moderate neuromuscular blockade.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36181085 PMCID: PMC9524859 DOI: 10.1097/MD.0000000000030702
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Demographic and clinical characteristics of all the enrolled patients.
| Moderate blockade (n = 34) | Deep blockade (n = 33) | ||
|---|---|---|---|
| Age (yr) | 44.2 ± 9.7 | 40.7 ± 9.35 | .14 |
| Height (cm) | 160.6 ± 4.8 | 160.6 ± 6.2 | .97 |
| Weight (kg) | 59.5 ± 8.2 | 59.0 ± 11.8 | .84 |
| ASA physical status (1/2/3) | 14/20/0 | 14/19/0 | .92 |
| Type of surgery | .52 | ||
| Hysterectomy (n) | 11 | 7 | |
| Myomectomy (n) | 13 | 14 | |
| Cystectomy (n) | 8 | 11 | |
| Salpingo-oophorectomy (n) | 2 | 1 | |
| Anesthesia time (min) | 115.09 ± 29.86 | 103.61 ± 27.71 | .11 |
| Operation time (min) | 72.85 ± 25.82 | 60.74 ± 23.59 | .05 |
| Recovery time(min) | 112.09 ± 68.16 | 134.97 ± 62.86 | .16 |
| Rocuronium dose (mg) | 52.94 ± 21.84 | 76.26 ± 22.18 | .000 |
| Remifentanil dose (µg) | 562.40 ± 320.90 | 528.20 ± 220.10 | .61 |
| Propofol dose (mg) | 857.00 ± 252.33 | 786.76 ± 259.47 | .27 |
| Hypertension (n) | 4 | 2 | .43 |
| Hypotension (n) | 1 | 1 | 1.00 |
| Additional rocuronium administration (n) | 8 | 0 |
Values are mean ± SD or numbers of patients (n).
ASA = American Society of Anesthesiologists, SD = standard deviation.
Demographic and clinical characteristics of the patients in groups M and D.
| Group M (n = 34) | Group D (n = 33) | ||
|---|---|---|---|
| Estimated blood loss (mL) | 50.90 ± 61.37 | 37.06 ± 46.77 | .30 |
| Surgical pain (NRS) | 5 (3.5, 7) | 5 (3, 6) | .21 |
| Fentanyl dose in PACU (µg) | 90.30 ± 19.60 | 82.35 ± 27.20 | .17 |
| Satisfaction of surgeon | 5 (4, 5) | 5 (5, 6) | .001[ |
| Hospital stay (d) | 5 (5, 5) | 5 (5, 5) | .81 |
Values are presented as mean ± SD and median (Q1, Q3).
Group D = deep neuromuscular blockade, Group M = moderate neuromuscular blockade, NRS = numerical rating scale scores (1–10; 1 = poor, 10 = good), PACU = postanesthesia care unit, SD = standard deviation.
Surgeon’s satisfaction with the surgical field was higher in group D than in group M.
Figure 1.Flow diagram showing patient flow according to the study protocol. ASA = American Society of Anesthesiologists, BMI = body mass index.
Figure 2.Comparison of stress hormone and glucose levels between the moderate and deep neuromuscular blockade groups. (A) Changes in serum cortisol levels. (B) Changes in serum ACTH levels. (C) Changes in serum glucose levels. ACTH = adrenocorticotropic hormone, Group D = deep neuromuscular blockade, Group M = moderate neuromuscular blockade, T0 = before surgery, T1 = end of surgery, T2 = 90 min after the surgery. †P < .01 compared with T0 within group. ‡P < .01 compared with T1 within group. §P > .05 between 2 groups.